Clinical Trial

Clinico-biological Data Collection Study of Metastatic Lung Cancer

Study acronym: EPICURE_LUNG
Recruiting
View on ClinicalTrials.gov →
Summary
RATIONALE : Currently, the mechanisms associated with the response or resistance to treatment are poorly understood and are multifactorial. These mechanisms involve clinical and biological factors associated with the host and the tumor and possibly the patient's psycho-social environment. PURPOSE : This trial will assess the use of a prospective database dedicated to patients with breast cancers that contains clinical data as well as epidemiological, psychological, emotional, social, imaging, biological and biopathological data. These data will allow a creation of new modelling algorithms in order to predict response and resistance to treatment.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-06-26; most recent amendment 2025-12-01.
Status change: Active, Not Recruiting → Recruiting 2025-12-01
Status change: Not Yet Recruiting → Active, Not Recruiting 2023-04-17
Trial Details
NCT Number NCT04944030
Lead Sponsor Institut Cancerologie de l'Ouest
Conditions Lung Cancer
Enrollment 200 participants
Start Date 2023-04-24
Primary Completion 2031-10 (estimated)
Study Completion 2031-10 (estimated)
Updated on ClinicalTrials.gov 2025-12-08